European CHMP recommends license extension for ceftazidime / avibactam (Zavicefta)
The license extension is for treatment of patients with bacteraemia. Ceftazidime / avibactam is currently licensed only for complicated intra-abdominal infection, urinary tract infection and hospital-acquired pneumonia.
Source:
European Medicines Agency